CM
AUPH icon

Caption Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Caption Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1M Buy
1,008,000
+948,300
+1,588% +$15.1M 0.08% 270
2026
Q1 		$885K Buy
59,700
+19,700
+49% +$288K 0.01% 1060
2025
Q4 		$638K Sell
40,000
-2,500
-6% -$35.4K ﹤0.01% 1194
2025
Q3 		$470K Sell
42,500
-198,000
-82% -$2.16M ﹤0.01% 1317
2025
Q2 		$2.04M Sell
240,500
-75,000
-24% -$601K 0.02% 708
2025
Q1 		$2.54M Sell
315,500
-188,800
-37% -$1.53M 0.02% 610
2024
Q4 		$4.53M Buy
504,300
+380,000
+306% +$3.1M 0.04% 395
2024
Q3 		$911K Buy
124,300
+64,300
+107% +$399K 0.01% 804
2024
Q2 		$343K Buy
+60,000
New +$316K 0.01% 879
2024
Q1 		– Sell
-218,000
Closed -$1.96M – 1198
2023
Q4 		$1.96M Buy
218,000
+168,000
+336% +$1.38M 0.03% 625
2023
Q3 		$389K Hold
50,000
– – 0.01% 988
2023
Q2 		$484K Sell
50,000
-100,000
-67% -$1.04M 0.01% 826
2023
Q1 		$1.64M Buy
150,000
+105,000
+233% +$925K 0.03% 504
2022
Q4 		$194K Sell
45,000
-25,000
-36% -$145K ﹤0.01% 1065
2022
Q3 		$525K Buy
70,000
+10,000
+17% +$86.6K 0.01% 1062
2022
Q2 		$603K Hold
60,000
– – 0.01% 1029
2022
Q1 		$743K Sell
60,000
-137,100
-70% -$2.12M 0.01% 1051
2021
Q4 		$4.51M Buy
197,100
+107,100
+119% +$2.54M 0.05% 487
2021
Q3 		$1.99M Sell
90,000
-70,000
-44% -$1.11M 0.02% 755
2021
Q2 		$2.07M Buy
160,000
+40,000
+33% +$510K 0.03% 665
2021
Q1 		$1.56M Sell
120,000
-101,200
-46% -$1.47M 0.03% 578
2020
Q4 		$3.06M Buy
221,200
+11,200
+5% +$163K 0.07% 337
2020
Q3 		$3.09M Sell
210,000
-62,200
-23% -$901K 0.07% 312
2020
Q2 		$4.42M Sell
272,200
-60,000
-18% -$961K 0.15% 190
2020
Q1 		$4.82M Buy
+332,200
New +$5.86M 0.27% 98

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caption Management's AUPH Position: Q2 2026 in Review

Caption Management opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 216,363 shares worth $3.67M. The stake represents 0.02% of the portfolio and ranks #686 among its holdings. This is a return to the name: Caption Management previously reported a position in AUPH as recently as Q3 2025.

Caption Management first reported a position in AUPH in Q4 2019 and has held it in 19 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Caption Management held 216,363 shares of Aurinia Pharmaceuticals worth $3.67M as of Q2 2026.
  • Aurinia Pharmaceuticals was a new Caption Management position in Q2 2026.
  • Aurinia Pharmaceuticals made up 0.02% of Caption Management's portfolio in Q2 2026, its #686 holding.
  • Caption Management first reported a position in Aurinia Pharmaceuticals in Q4 2019 and has held it in 19 quarters since.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.